caraballo

Also Caraballo was the one who was actually harassing and doxxing.

The highest post in the chain we're in: >PSA: author is Alejandra Caraballo [...] The reply: >Yep, this whole article is basically just -->his<-- very biased opinions [...] My reply: >Alejandra Caraballo is a woman.

Now, you might frame this as Singal "harassing" Caraballo, but if you look at what he's written, he's reporting on Caraballo who is the one actually harassing and doxxing.

For instance, Alejandra Caraballo, like it or not, is a public figure.

> "He's putting Yoel's life in danger and he knows it," tweeted Alejandra Caraballo, an instructor at Harvard Law School.

> In a post on Twitter/X, Caraballo accused Cass and the review team of holding trans healthcare to an “impossible standard”.

This is unfortunately quite a typical tactic of activists like Caraballo.

Using a different method than Pekar et al., Caraballo-Ortiz et al.

Were you correcting a mistake or asserting your/Caraballo's opinion?

> She was referring to Alejandra Caraballo, an American attorney, transgender woman and instructor at Harvard Law School’s Cyberlaw Clinic.

Cass told The Times last week how difficult it would be to use blind control studies in relation to trans patients, for the same reasons identified by Caraballo.

NBC News reporter Ben Collins, Harvard Law Cyberlaw Clinic's Alejandra Caraballo, and countless other highly-followed Twitter accounts have already shared their intention to block all Twitter Blue subscribers.

Now, you might frame this as Singal "harassing" Caraballo, but if you look at what he's written, he's reporting on Caraballo who is the one actually harassing and doxxing.

> "He's putting Yoel's life in danger and he knows it," tweeted Alejandra Caraballo, an instructor at Harvard Law School.

> In a post on Twitter/X, Caraballo accused Cass and the review team of holding trans healthcare to an “impossible standard”.

> As for Caraballo’s claim that the review team “disregarded nearly all studies”, Cass pointed out that 60 out of 103 studies reviewed were used for the conclusions.

For instance, Alejandra Caraballo, like it or not, is a public figure.

This is unfortunately quite a typical tactic of activists like Caraballo.

Using a different method than Pekar et al., Caraballo-Ortiz et al.